3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Carcinoma, Renal Cell
73
Neoplasm Metastasis
30
Kidney Neoplasms
26
Neoplasms
19
Breast Neoplasms
14
Prostatic Neoplasms
12
Urinary Bladder Neoplasms
10
Melanoma
9
Gastrointestinal Stromal Tumors
9
Brain Neoplasms
9
Glioblastoma
8
Sarcoma
7
Carcinoma, Non-Small-Cell Lung
7
Liver Neoplasms
6
Carcinoma, Hepatocellular
6
Recurrence
5
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Esophageal Neoplasms
5
Colorectal Neoplasms
5
Thyroid Neoplasms
4
Solid Tumors
4
Osteosarcoma
4
Lung Neoplasms
4
Leukemia, Myeloid, Acute
4
Adenocarcinoma
4
Uveal Melanoma
3
Thymoma
3
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Oxaliplatin
3
Capecitabine
3
Irinotecan
2
Gemcitabine
2
Cyclophosphamide
2
Colonoscopy
2
Bupivacaine
2
Aspirin
2
Ascorbic Acid
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
trametinib
1
penpulimab
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
hetrombopag
1
halofantrine
1
guadecitabine
1
gadolinium ethoxybenzyl DTPA
1
gadobutrol
1
enoxaparin sodium
1
copper dotatate CU-64
1
camrelizumab
1
aumolertinib
1
XELOX
1
Ursodeoxycholic Acid
1
Urine Specimen Collection
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Digestive System Diseases
×
Sunitinib
×
Clear all
NCT01215578
2015-04-30
NET
Assistance Publique - Hôpitaux de Paris
Phase 2
Terminated
33 enrolled